|
Ronald C. Griffith, Ph.D., is Genelabs� Chief Scientific Officer. Dr. Griffith joined Genelabs in 2001 as Vice President, Research. Prior to joining Genelabs, Dr. Griffith was Vice President of Medicinal Chemistry with Isis Pharmaceuticals Corp. From February 2000 through May 2001 he was Vice President of Chemistry at X -Ceptor Therapeutics. Prior to that, Dr. Griffith was Director of Chemical Sciences at Tanabe Research Laboratories, USA from 1997 through 2000 and, from 1995 until he joined Tanabe, Dr. Griffith was Director of Chemistry with Astra Pharmaceuticals (acquired by AstraZeneca). Dr. Griffith was also Director of Chemistry at Fison Pharmaceuticals from 1988 to 1995 and Director of Medicinal Chemistry at Pennwalt Corporation from 1986 to 1988, joining Pennwalt in 1974. Dr. Griffith received his B.S. degree from Alfred University and his Ph.D. in Organic Chemistry from Syracuse University and was a post-doctoral fellow at California Institute of Technology. | 